Evidence map›Paper›PMID 32198703›Full record

ReviewCurrent diabetes reports2020

Novel Challenges in Aging with Type 1 Diabetes.

Jeoffrey A Bispham, Allyson S Hughes, Kimberly A Driscoll, Alicia H McAuliffe-Fogarty

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. "They Did Not Anticipate Anybody Living a Full Life": Perspectives on Aging With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025
    Article
  7. Article
  8. "Journal of clinical & translational endocrinology · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeoffrey A BisphamT1D Exchange, 11 Avenue de Lafayette, Boston, MA, 02111, USA. jbispham@t1dexchange.org.
Allyson S HughesT1D Exchange, 11 Avenue de Lafayette, Boston, MA, 02111, USA.
Kimberly A DriscollDepartment of Clinical and Health Psychology, University of Florida, Gainesville, FL, 32610-0165, USA.
Alicia H McAuliffe-FogartyT1D Exchange, 11 Avenue de Lafayette, Boston, MA, 02111, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewDue to treatment advancements, individuals with type 1 diabetes (T1D) are living longer, presenting a unique understudied population with advanced complex needs. This article is a review of the aging literature in T1D and identifies existing gaps while serving as a call to the research community. RECENT

findingsRecent studies have identified an association between cognitive impairment and glycemic variability, as well as increased risk and frequency of hypoglycemia in older adults with T1D. However, limited research exists about additional physical and mental health conditions and barrier to successful treatment in this population. Older adults may experience both age- and diabetes-related barriers to diabetes management. Due to the scarcity of aging T1D research, current treatment guidelines for this age group are based on type 2 diabetes research. There is a critical need to further investigate the physical and mental effects of T1D and aging as well as public health policy; insurance challenges; and needs for support and interventions for older adults with T1D.

Indexed as

AgingDiabetes ComplicationsDiabetes Mellitus, Type 1Blood GlucoseCognition DisordersHumansHypoglycemiaBlood GlucoseAgingHypoglycemiaMental healthOlder adultsType 1 diabetes

Identifiers

PMID32198703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.